Blueprint Medicines Corporation
Overview
Blueprint Medicines Corporation is a biopharmaceutical company focused on developing targeted therapies for genomic abnormalities in cancer and rare diseases. The company utilizes a deep understanding of genomics to create precision medicines that address the unmet needs of patients worldwide.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Blueprint Medicines Corporation in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.